| Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2 (NCT04222985) | Sanofi Pasteur, a Sanofi Company | 2020-02-18 |
| Maintenance Dose Study of GEN-003 in Subjects With Genital Herpes Infection (NCT03146403) | Genocea Biosciences, Inc. | 2017-05-24 |
| The VIBLOK SAfety and perFormancE Trial (NCT03080961) | CLJI Worldwide | 2017-03-27 |
| Melatonin Effects on Genital Herpes in Brazilian Women (NCT03831165) | University of Sao Paulo General Hospital | 2015-09-02 |
| Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes (NCT01658826) | AiCuris Anti-infective Cures AG | 2012-10-01 |
| Efficacy of Oral Famciclovir 125mg Comparing to Aciclovir 200 mg Treatment in Patients With Active Recurrent Genital Herpes (NCT01281007) | EMS | 2012-07-01 |
| Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2 (NCT01112956) | Centers for Disease Control and Prevention | 2009-07-01 |
| GUD Clinical and Virologic Response to Acyclovir in HIV Negative African Women (NCT00808405) | University of Washington | 2009-01-01 |
| Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 (NCT01346475) | University of Washington | 2008-11-01 |
| A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation (NCT00723229) | University of Washington | 2008-08-01 |
| Effect of HSV-2 Suppressive Therapy on Sexual Behavior (NCT00495716) | University of Washington | 2008-01-01 |
| Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV (NCT00527618) | University of Washington | 2007-12-01 |
| Patient-initiated Episodic Treatment of Recurrent Genital Herpes in Black Patients (NCT00477334) | Novartis | 2007-06-01 |
| HSV-2 Shedding Resolution After Acyclovir Treatment (NCT00495573) | University of Washington | 2007-06-01 |
| Special Drug Use Investigation for VALTREX (Valaciclovir) (Suppression Prophylaxis) (NCT01390805) | GlaxoSmithKline | 2006-11-01 |
| Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fed Conditions (NCT01132716) | Roxane Laboratories | 2006-09-01 |
| Bioequivalency Study of Valacyclovir Hydrochloride 1000 mg Under Fasting Conditions (NCT01132729) | Roxane Laboratories | 2006-09-01 |
| Trial Evaluating Safety, Tolerability and Immune Response of AG-707 (NCT00231049) | Agenus Inc. | 2006-03-01 |
| Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes (NCT00306787) | Novartis Pharmaceuticals | 2006-03-01 |
| Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection (NCT00262106) | Endo USA Inc., a Keenova Therapeutics Company | 2005-10-01 |
| A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding (NCT00129818) | Novartis | 2004-07-01 |
| Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community (NCT00124878) | Wawer, Maria J., M.D. | 2003-08-01 |